Kidney image analysis services
Quantitative evaluation of renal pathology images plays an important role for your drug development studies. It will increase the precision and reproducibility of biomarker scoring and provides objective information about the status of the kidney specimens.
Aiosyn harnesses the power of cutting-edge AI technology to quantify kidney histopathology specimens. Our NephroPath1 platform consists of algorithms for AI-enabled kidney biomarker scoring and is offered through our AI-assisted image analysis services.
1. The NephroPath platform is for Research Use Only and should not be used for diagnostic procedures.
Aiosyn’s streamlined project workflow
AI-assisted image analyses
-
Standard whole kidney analysis
-
Custom kidney analysis
-
Enrich your study with AI-powered whole kidney tissue quantification. We offer insights into your data through:
Accurate segmentation and delineation of relevant kidney structures
Extent of glomerulosclerosis and fibrosis
(Immune) cell quantification, including spatial relation to tissue
Online/offline access to all results
-
Leverage Aiosyn’s expertise in AI and the latest technology to create a tailored analysis for kidney tissue. We offer development and prototyping of robust and performant models with a quick turn-around time:
IHC/Biomarker quantification in specific animal models
Treatment response grouping
Tissue microenvironment analysis
How can we assist your team?
- Detailed reports on kidney tissue analysis swiftly upon data submission.
- Precise quantification to improve the reproducibility of results.
- Improved objectivity of pathologist’s assessments in multi-center (pre)clinical studies.
- Customized projects for new and existing biomarkers.
Aiosyn's Kidney image analysis news
-
Aiosyn and HistoWiz partner to improve kidney disease research through AI-powered preclinical studies
22 May, 2024 • By Anna Correas GrifollRead more -
Aiosyn and Physiogenex partner to enhance kidney disease drug development
14 March, 2024 • By Kama WitkowskaRead more -
Aiosyn announces the formation of a Scientific Advisory Board to guide the continued development of its Kidney AI Suite
12 October, 2023 • By Anna Correas GrifollRead more
